Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Are there candidates for high-dose chemotherapy in ovarian carcinoma?

Sabatier R, Gonçalves A, Bertucci F, Capiello MA, Rousseau F, Lambaudie E, Chabannon C, Viens P, Extra JM.

J Exp Clin Cancer Res. 2012 Oct 16;31:87. doi: 10.1186/1756-9966-31-87.

PMID:
23072336
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results.

Legros M, Dauplat J, Fleury J, Cure H, Suzanne F, Chassagne J, Bay JO, Sol C, Canis M, Condat P, Choufi B, Tavernier F, Glenat C, Chollet P, Plagne R.

J Clin Oncol. 1997 Apr;15(4):1302-8.

PMID:
9193321
[PubMed - indexed for MEDLINE]
Free Article
3.

High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.

Bertucci F, Viens P, Delpero JR, Bardou VJ, Faucher C, Houvenaeghel G, Maraninchi D.

Bone Marrow Transplant. 2000 Jul;26(1):61-7.

PMID:
10918406
[PubMed - indexed for MEDLINE]
Free Article
4.
5.

A systematic overview of chemotherapy effects in ovarian cancer.

Högberg T, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):340-60. Review.

PMID:
11441940
[PubMed - indexed for MEDLINE]
6.

High dose chemotherapy with autologous stem cell support in the treatment of patients with ovarian carcinoma: long term results for 105 patients.

Shinozuka T, Miyamoto T, Muramatsu T, Hirasawa T, Murakami M, Makino T, Tanaka Y.

Cancer. 1999 Apr 1;85(7):1555-64.

PMID:
10193946
[PubMed - indexed for MEDLINE]
7.

Complete response after high-dose chemotherapy and autologous hemopoietic stem cell transplatation in metastatic breast cancer results in survival benefit.

Kurian S, Qazilbash M, Fay J, Wolff S, Herzig R, Hobbs G, Bunner P, Weisenborn R, Aya-Ay M, Lynch J, Ericson S.

Breast J. 2006 Nov-Dec;12(6):531-5.

PMID:
17238982
[PubMed - indexed for MEDLINE]
8.

High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.

Wheeler C, Eickhoff C, Elias A, Ibrahim J, Ayash L, McCauley M, Mauch P, Schwartz G, Eder JP, Mazanet R, Ferrara J, Rimm IJ, Guinan E, Bierer B, Gilliland G, Churchill WH, Ault K, Parsons S, Antman K, Schnipper L, Tepler I, Gaynes L, Frei E 3rd, Kadin M, Antin J.

Biol Blood Marrow Transplant. 1997 Jun;3(2):98-106.

PMID:
9267670
[PubMed - indexed for MEDLINE]
9.

First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up.

Fujiwara K, Sakuragi N, Suzuki S, Yoshida N, Maehata K, Nishiya M, Koshida T, Sawai H, Aotani E, Kohno I.

Gynecol Oncol. 2003 Sep;90(3):637-43. Erratum in: Gynecol Oncol. 2003 Dec;91(3):662.

PMID:
13678738
[PubMed - indexed for MEDLINE]
10.

High-dose chemotherapy with peripheral blood stem cell support for stage IIIB inflammatory carcinoma of the breast.

Schwartzberg L, Weaver C, Lewkow L, McAneny B, Zhen B, Birch R, West W, Tauer K, Buckner C.

Bone Marrow Transplant. 1999 Nov;24(9):981-7.

PMID:
10556957
[PubMed - indexed for MEDLINE]
Free Article
11.

A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle.

Bashey A, Corringham S, Garrett J, Lane TA, Gilpin EA, Corringham RE, Law P, Ho AD.

Bone Marrow Transplant. 2000 Mar;25(5):519-24.

PMID:
10713629
[PubMed - indexed for MEDLINE]
Free Article
12.

High-dose chemotherapy as a consolidation approach in advanced ovarian cancer: long-term results.

Salerno MG, Ferrandina G, Greggi S, Pierelli L, Menichella G, Leone G, Scambia G, Mancuso S.

Bone Marrow Transplant. 2001 May;27(10):1017-25.

PMID:
11438815
[PubMed - indexed for MEDLINE]
Free Article
13.

Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre study.

Gonçalves A, Delva R, Fabbro M, Gladieff L, Lotz JP, Ferrero JM, Linassier C, Cottu PH, Viens P, Extra JM.

Bone Marrow Transplant. 2006 Apr;37(7):651-9.

PMID:
16501596
[PubMed - indexed for MEDLINE]
14.

High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT).

Bengala C, Guarneri V, Ledermann J, Rosti G, Wandt H, Lotz JP, Cure JH, Orlandini C, Ferrante P, Conte PF, Demirer T; EBMT Solid Tumor Working Party.

Bone Marrow Transplant. 2005 Jul;36(1):25-31.

PMID:
15908977
[PubMed - indexed for MEDLINE]
15.

High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II study.

Toh HC, McAfee SL, Sackstein R, Multani P, Cox BF, Garcia-Carbonero R, Colby C, Spitzer TR.

Bone Marrow Transplant. 2000 Jan;25(1):19-24.

PMID:
10654009
[PubMed - indexed for MEDLINE]
Free Article
16.

High dose chemotherapy and autologous stem cell transplantation for poor risk and recurrent non-Hodgkin's lymphoma: a single-center experience of 50 patients.

Shim BY, Lee MA, Byun JH, Roh SY, Song CW, Park JN, Lee JW, Min WS, Hong YS, Kim CC.

Korean J Intern Med. 2004 Jun;19(2):114-20.

PMID:
15366643
[PubMed - indexed for MEDLINE]
Free Article
17.

High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients.

Stiff PJ, Bayer R, Kerger C, Potkul RK, Malhotra D, Peace DJ, Smith D, Fisher SG.

J Clin Oncol. 1997 Apr;15(4):1309-17.

PMID:
9193322
[PubMed - indexed for MEDLINE]
Free Article
18.

A phase I-II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma.

Weaver CH, Greco FA, Hainsworth JD, Zhen B, Baldwin P, Wittlin F, Lewis M, West WH, Schwartzberg L, Buckner CD.

Bone Marrow Transplant. 1997 Nov;20(10):847-53.

PMID:
9404925
[PubMed - indexed for MEDLINE]
Free Article
19.

High-dose chemotherapy with haematopoietic stem-cell support in patients with poor prognosis, relapsed or refractory germ cell tumours.

El-Helw LM, Naik JD, Chester JD, Joffe JK, Selby PJ, Coleman RE.

BJU Int. 2006 Sep;98(3):519-25.

PMID:
16925746
[PubMed - indexed for MEDLINE]
20.

High-dose chemotherapy with hematopoietic stem cell support in patients with advanced epithelial ovarian cancer: analysis of 67 patients treated in a single institution.

Bertucci F, Viens P, Gravis G, Blaise D, Faucher C, Oziel-Taoeb S, Bardou VJ, Jacquemier J, Delpero JR, Maraninchi D.

Anticancer Res. 1999 Mar-Apr;19(2B):1455-61.

PMID:
10365123
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk